SEC Company Response from Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087) (TECX) — Jun 18, 2018
Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087)
Date: June 18, 2018 · CIK: 0001681087 · Accession: 0001193125-18-195611
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225213
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Dorrie Yale Re: AVROBIO, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-225213
Dear Ms. Yale:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), AVROBIO, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 20, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling James Xu at (617) 570-1483. We also respectfully request that a copy of the written order from the Securities and Exchange Commission (the “Commission”) verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: James Xu, by facsimile to (617) 523-1231.
If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483.
Sincerely,
AVROBIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR June 18, 2018 United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Attention: Dorrie Yale Re: AVROBIO, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-225213 Dear Ms. Yale: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), AVROBIO, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 20, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling James Xu at (617) 570-1483. We also respectfully request that a copy of the written order from the Securities and Exchange Commission (the “Commission”) verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: James Xu, by facsimile to (617) 523-1231. If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483. Sincerely, AVROBIO, INC. /s/ Geoff MacKay Geoff MacKay President and Chief Executive Officer cc: Katina Dorton, Chief Financial Officer, AVROBIO, Inc. Arthur McGivern, Esq., Goodwin Procter LLP James Xu, Esq., Goodwin Procter LLP